145 related articles for article (PubMed ID: 6089145)
1. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
Katsuura G; Hsiao S; Itoh S
Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
[TBL] [Abstract][Full Text] [Related]
3. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
[TBL] [Abstract][Full Text] [Related]
4. Differential antagonism by proglumide of various CCK-mediated effects in mice.
Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
[TBL] [Abstract][Full Text] [Related]
5. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
Sakatani N; Inui A; Baba S
Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin octapeptide, proglumide, and passive avoidance in rats.
Deupree D; Hsiao S
Peptides; 1987; 8(1):25-8. PubMed ID: 3575151
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin octapeptide, proglumide, and conditioned taste avoidance in rats.
Deupree D; Hsiao S
Physiol Behav; 1987; 41(2):125-8. PubMed ID: 3685161
[TBL] [Abstract][Full Text] [Related]
8. Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
Inui A; Inoue T; Sakatani N; Oya M; Morioka H; Baba S
Brain Res; 1987 Aug; 417(2):355-9. PubMed ID: 3651819
[TBL] [Abstract][Full Text] [Related]
9. Unsulfated CCK-8 not blocked by proglumide or CR 1409 in the mouse abdominal irritant-induced stretching assay: possible central site of action.
Ambrose FG; Barbaz BS; Autry WL; Browne RG; Liebman JM
Peptides; 1989; 10(1):31-4. PubMed ID: 2748423
[TBL] [Abstract][Full Text] [Related]
10. Effect of proglumide on rat pancreatic growth.
Yamaguchi T; Tabata K; Johnson LR
Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
[TBL] [Abstract][Full Text] [Related]
11. The effects of the cholecystokinin antagonist, proglumide, on gonadotropin release in the rat.
Vijayan E; McCann SM
Brain Res Bull; 1986 Apr; 16(4):533-6. PubMed ID: 3087585
[TBL] [Abstract][Full Text] [Related]
12. The effects of the cholecystokinin antagonist, proglumide, on prolactin secretion in the rat.
Vijayan E; McCann SM
Life Sci; 1987 Feb; 40(7):629-34. PubMed ID: 3807652
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
Katsuura G; Itoh S
Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
[TBL] [Abstract][Full Text] [Related]
14. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats.
Makovec F; Bani M; Chistè R; Revel L; Rovati LC; Setnikar I
Regul Pept; 1986 Dec; 16(3-4):281-90. PubMed ID: 3562900
[TBL] [Abstract][Full Text] [Related]
15. Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.
Vasar E; Lang A; Harro J; Bourin M; Bradwejn J
Neuropharmacology; 1994 Jun; 33(6):729-35. PubMed ID: 7936110
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
Tanimoto K; Tamminga CA; Chase TN; Nilaver G
Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
[TBL] [Abstract][Full Text] [Related]
17. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
Corp ES; Curcio M; Gibbs J; Smith GP
Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
[TBL] [Abstract][Full Text] [Related]
18. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin.
Khosla S; Crawley JN
Life Sci; 1988; 42(2):153-9. PubMed ID: 3336275
[TBL] [Abstract][Full Text] [Related]
19. Proglumide fails to increase food intake after an ingested preload.
Schneider LH; Gibbs J; Smith GP
Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
Schick RR; Yaksh TL; Go VL
Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
